ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Transcenta Announced Successful First Patient Dosed in Phase I Clinical Study of TST001 Combined with CAPOX for the Treatment of Patients with First-line Locally Advanced Unresectable or Metastatic Ga
April 19, 2021Transcenta Holding Limited (Transcenta), a clinical stage global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, today announced the first patient has been ... -
Transcenta Announces Appointments of Dr. Xichen Zhang as Senior Vice President of Manufacturing and Dr. Steven Yu as Senior Vice President of DMPK and Translational Science
March 24, 2021Transcenta today announced the expansion of its senior management team by appointing Dr. Xichen Zhang as Senior Vice President of Manufacturing and Dr. Steven Yu as Senior Vice President of DMPK & Translational Science. -
Transcenta Closes $105 Million in Crossover Financing
December 23, 2020Transcenta Holding Limited, a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, announces today the completion of a 105 million USD crossover financing. -
Transcenta Holding Secures $100 Million Series B Plus Financing
January 09, 2020Mr. Shen Qi, Senior Vice President and Head of Healthcare Investment at Fortune Capital, said "We appreciate having the chance to support Transcenta team in this financing round together with the other investors.
Pharma Sources Insight January 2025
